Recruiting

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeutic management as needed.

ClinicalTrials.gov IDNCT05178498

PhaseNot Applicable

Enrollment960

SponsorOhio State University Comprehensive Cancer Center

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Carcinoma, Breast Lobular Carcinoma In Situ, Breast Sclerosing Adenosis

About this study

Interventions

Procedure: Follow-Up — Undergo follow up
Procedure: Physical Examination — Complete physical measurements
Other: Questionnaire Administration — Complete questionnaires

Primary outcomes

Time to breast cancer events during study follow up (Up to 10 years)

Eligibility information

Inclusion Criteria: * Age \>= 18 years * Established in the high risk clinic at OSUCCC- James (includes patients with family history of breast cancer \[BC\], known genetic predisposition, personal history of known atypia/breast lobular carcinoma in situ \[LCIS\], or prior chest wall radiation) * Patients at high risk for BC established in the surgical oncology clinic at Stefanie Spielman Comprehensive Breast Center (SSCBC), with one of the following diagnoses: Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), sclerosing adenosis (SA), or radial scars (RS) * Able to read and understand English * Able to provide informed consent * Must consent to continued follow-up of medical records during the study period Exclusion Criteria: * Prisoners * Not able to speak and understand English * Known personal history of ductal carcinoma in situ (DCIS) or Invasive BC

Study locations

Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.